Journal of the American Chemical Society
Article
component fusions without the need for solid support
tethering or removable protective groups (Figure 5F,G). In
addition, some higher order modifications appeared, arising
from residual disulfide formation between unreacted thiols in
the first step. To combat the undesired formation of disulfide
bonds between thiols in the protein coupling partner, we
suggest pretreating these proteins with a 2x molar excess of
TCEP in pH 7.0 Tris-HCl buffer, followed by an exchange into
the reaction buffer via spin filtration. This pretreatment step
was used for all subsequent reactions.
AUTHOR INFORMATION
Corresponding Author
■
Matthew B. Francis − Department of Chemistry, University of
California, Berkeley, California 94720, United States;
Materials Sciences Division, Lawrence Berkeley National
Laboratories, Berkeley, California 94720, United States;
Authors
To evaluate the potential of an iterative tyrosinase approach
for the creation of protein trimers, Y200C GFP-E4Y was
combined with a MYGGS-tagged nanoluciferase and 20 U/mL
abTYR to activate the neutral luciferase tag selectively (Figure
6A−C). Clean conversion to the Y200C GFP-E4Y-nano-
luciferase dimer was observed, with no excess oxidation. To
remove any unreacted starting material, the solution was
purified using a 50 kDa MWCO spin concentrator (Figure
6C). As a third component, the thiol-containing S152C-
mCherry was added to the dimer solution with 20 U/mL
D55R megaTYR to activate the EEEEY tag on the GFP. This
strategy led to smooth conversion to the mCherry-GFP-
luciferase trimer (Figure 6D). We saw 100% conversion from
the dimer to the final product, indicating that megaTYR is
capable of catalyzing tyrosinase oxidation on anionic tags even
in the presence of multiprotein complexes. The trifunctional
nature of the construct identity was further validated by
luminescence and fluorescence measurements. Upon introduc-
ing the nanoLuc substrate, FRET was observed between the
luciferase, GFP, and mCherry subunits. In addition, direct
excitation of the GFP fluorophore led to emission from the
mCherry segment via energy transfer (Figure S5). This new
capability to oxidize tyrosine residues in different charge
contexts iteratively highlights the potential of this system to
generate complex protein products for future applications.
Conclusion. Here, we show that recombinantly expressed
tyrosinases are successful activators of terminal tyrosine
residues on a variety of protein and peptide substrates. The
results from the megaTYR mutant screen show that bacterially
derived tyrosinases possess sufficient selectivity to mediate
protein−protein coupling reactions through tyrosine-cysteine
bond formation and can be engineered to alter their substrate
preferences. The success at modulating the charge preference
of this enzyme indicates that it is tolerant toward mutation and
can be engineered to achieve orthogonal reactivity preferences
to those of abTYR. The result of these efforts is the ability to
sequentially activate tyrosine residues based on their charge
context, or CDSAT. The protein trimers created using CDSAT
show that minimal engineering is required to produce a system
capable of creating higher-order protein constructs while
controlling their orientation via cyteine position. Such
multivalent conjugates have tremendous potential for materi-
als, therapeutic, and diagnostic applications.
Casey S. Mogilevsky − Department of Chemistry, University
of California, Berkeley, California 94720, United States;
Marco J. Lobba − Department of Chemistry, University of
California, Berkeley, California 94720, United States;
Daniel D. Brauer − Department of Chemistry, University of
California, Berkeley, California 94720, United States;
Alan M. Marmelstein − Department of Chemistry, University
of California, Berkeley, California 94720, United States;
Johnathan C. Maza − Department of Chemistry, University of
California, Berkeley, California 94720, United States;
Jamie M. Gleason − Department of Chemistry, University of
California, Berkeley, California 94720, United States
Jennifer A. Doudna − Department of Chemistry, Department
of Molecular and Cell Biology, and Howard Hughes Medical
Institute, University of California, Berkeley, California 94720,
United States; Gladstone Institutes, San Francisco, California
94158, United States; Innovative Genomics Institute,
University of California, Berkeley, California 94720, United
States
Complete contact information is available at:
Author Contributions
$These authors contributed equally
Notes
The authors declare the following competing financial
interest(s): M.B.F is the Chair of the UC Berkeley Department
of chemistry; a co-founder of Catena Biosciences; and a
scientific adviser to Catena Biosciences. M.J.L is a co-founder
of Catena Biosciences. The Regents of the University of
California have patents pending for the use of tyrosinase in the
manner described herein on which the authors are inventors.
ACKNOWLEDGMENTS
■
The authors thank the Zhang lab for making available the I-
TASSER/. The authors also thank Dr. Kathy Durkin and Dr.
Dave Small and the MGCF Facility for providing computa-
tional resources for the electrostatics calculations. Computa-
tional work was supported by NIH Grant: S10OD023532.
This work was supported by NIH Grant: R01 GM138693.
ASSOCIATED CONTENT
* Supporting Information
■
sı
The Supporting Information is available free of charge at
REFERENCES
■
(1) Zeng, Y.-S.; Gao, R.-C.; Wu, T.-W.; Cho, C.; Tan, K.-T.
Bioconjugate Chem. 2016, 27, 1872−1879.
Experimental procedures, full mass spectra of key
proteins before and after coupling, protein sequences,
and other relevant data (PDF)
H
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX